Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 445 to 447 of 447 entries
Sorted by: Best Match Show Resources per page
Spontaneous Ejaculation: A Focused Review for the Clinicians.

Sexual medicine reviews

Abdel-Hamid IA, Ali OI.
PMID: 33262094
Sex Med Rev. 2021 Jul;9(3):406-422. doi: 10.1016/j.sxmr.2020.11.001. Epub 2020 Nov 28.

INTRODUCTION: The process of ejaculation has important meanings not only for its association with orgasm but also for the timing to ejaculate in the context of sexual activity. Spontaneous (involuntary) ejaculation (SE) without any sexual stimulation is a distressing...

Cite
Abdel-Hamid IA, Ali OI. Spontaneous Ejaculation: A Focused Review for the Clinicians. Sex Med Rev. 2020;9(3):406-422doi: 10.1016/j.sxmr.2020.11.001.
Abdel-Hamid, I. A., & Ali, O. I. (2021). Spontaneous Ejaculation: A Focused Review for the Clinicians. Sexual medicine reviews, 9(3), 406-422. https://doi.org/10.1016/j.sxmr.2020.11.001
Abdel-Hamid, Ibrahim A, and Ali, Omar I. "Spontaneous Ejaculation: A Focused Review for the Clinicians." Sexual medicine reviews vol. 9,3 (2021): 406-422. doi: https://doi.org/10.1016/j.sxmr.2020.11.001
Abdel-Hamid IA, Ali OI. Spontaneous Ejaculation: A Focused Review for the Clinicians. Sex Med Rev. 2021 Jul;9(3):406-422. doi: 10.1016/j.sxmr.2020.11.001. Epub 2020 Nov 28. PMID: 33262094.
Copy Download .nbib Format: NLM
Using Medicare Data to Assess the Proarrhythmic Risk of Non-Cardiac Treatment Drugs that Prolong the QT Interval in Older Adults: An Observational Cohort Study.

Drugs - real world outcomes

Fung KW, Baye F, Kapusnik-Uner J, McDonald CJ.
PMID: 33569737
Drugs Real World Outcomes. 2021 Jun;8(2):173-185. doi: 10.1007/s40801-021-00230-1. Epub 2021 Feb 10.

INTRODUCTION: Serious cardiac arrhythmias caused by QT-prolonging drugs are difficult to predict based on physiological measurement and pre-approval clinical trials. Post-marketing surveillance and monitoring are important to generate safety data.OBJECTIVES: To assess whether an observational study using Medicare claims...

Cite
Fung KW, Baye F, Kapusnik-Uner J, et al. Using Medicare Data to Assess the Proarrhythmic Risk of Non-Cardiac Treatment Drugs that Prolong the QT Interval in Older Adults: An Observational Cohort Study. Drugs Real World Outcomes. 2021;8(2):173-185doi: 10.1007/s40801-021-00230-1.
Fung, K. W., Baye, F., Kapusnik-Uner, J., & McDonald, C. J. (2021). Using Medicare Data to Assess the Proarrhythmic Risk of Non-Cardiac Treatment Drugs that Prolong the QT Interval in Older Adults: An Observational Cohort Study. Drugs - real world outcomes, 8(2), 173-185. https://doi.org/10.1007/s40801-021-00230-1
Fung, Kin Wah, et al. "Using Medicare Data to Assess the Proarrhythmic Risk of Non-Cardiac Treatment Drugs that Prolong the QT Interval in Older Adults: An Observational Cohort Study." Drugs - real world outcomes vol. 8,2 (2021): 173-185. doi: https://doi.org/10.1007/s40801-021-00230-1
Fung KW, Baye F, Kapusnik-Uner J, McDonald CJ. Using Medicare Data to Assess the Proarrhythmic Risk of Non-Cardiac Treatment Drugs that Prolong the QT Interval in Older Adults: An Observational Cohort Study. Drugs Real World Outcomes. 2021 Jun;8(2):173-185. doi: 10.1007/s40801-021-00230-1. Epub 2021 Feb 10. PMID: 33569737; PMCID: PMC7875170.
Copy Download .nbib Format: NLM
Concomitant drugs associated with increased mortality for MDMA users reported in a drug safety surveillance database.

Scientific reports

Cohen IV, Makunts T, Abagyan R, Thomas K.
PMID: 33727616
Sci Rep. 2021 Mar 16;11(1):5997. doi: 10.1038/s41598-021-85389-x.

3,4-Methylenedioxymethamphetamine (MDMA) is currently being evaluated by the Food and Drug Administration (FDA) for the treatment of post-traumatic stress disorder (PTSD). If MDMA is FDA-approved it will be important to understand what medications may pose a risk of drug-drug...

Cite
Cohen IV, Makunts T, Abagyan R, et al. Concomitant drugs associated with increased mortality for MDMA users reported in a drug safety surveillance database. Sci Rep. 2021;11(1):5997doi: 10.1038/s41598-021-85389-x.
Cohen, I. V., Makunts, T., Abagyan, R., & Thomas, K. (2021). Concomitant drugs associated with increased mortality for MDMA users reported in a drug safety surveillance database. Scientific reports, 11(1), 5997. https://doi.org/10.1038/s41598-021-85389-x
Cohen, Isaac V, et al. "Concomitant drugs associated with increased mortality for MDMA users reported in a drug safety surveillance database." Scientific reports vol. 11,1 (2021): 5997. doi: https://doi.org/10.1038/s41598-021-85389-x
Cohen IV, Makunts T, Abagyan R, Thomas K. Concomitant drugs associated with increased mortality for MDMA users reported in a drug safety surveillance database. Sci Rep. 2021 Mar 16;11(1):5997. doi: 10.1038/s41598-021-85389-x. PMID: 33727616; PMCID: PMC7966744.
Copy Download .nbib Format: NLM
Showing 445 to 447 of 447 entries